Genetic studies showed that catalase is involved in metabolic syndromes, including obesity, type 2 diabetes, atherosclerosis, hyperglycemia, dyslipidemia, and hypertension32–34. Here, CAT is linked to obesity due to melanocortin 4 receptor deficiency.